1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

TDACW
Translational Development Acquisition Corp.US flagNASDAQ Global Market
1.41
USD
-0.06
- -
246.43MMarket Cap

Total Valuation

Translational Development Acquisition Corp. carries a market capitalization of 246.43M, placing it among publicly traded companies globally. Its enterprise value stands at 475,370.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap246.43M
Enterprise Value475,370.00

Share Statistics

Translational Development Acquisition Corp. currently has 21.91M shares outstanding.

Shares Outstanding21.91M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Financial Position

Translational Development Acquisition Corp. maintains a current ratio of 0.09, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.

Current Ratio0.09
Quick Ratio0.03
Debt / Equity0.28
Debt / EBITDA-0.57
Interest CoverageN/A

Financial Efficiency

Translational Development Acquisition Corp. posts a return on equity of 3.58 and a return on invested capital of -0.51.

Return on Equity (ROE)3.58
Return on Assets (ROA)3.45
Return on Invested Capital (ROIC)-0.51
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Stock Price Statistics

Translational Development Acquisition Corp.'s stock has gained approximately 511.18336% over the past 52 weeks. The 50-day moving average sits at 0.75, while the 200-day moving average is 0.40.

Beta (5Y)N/A
52-Week Price Change511.18336%
50-Day Moving Average0.75
200-Day Moving Average0.40
Average Volume (20 Days)N/A

Income Statement

EBITDA reached -878,291.00, while operating income came in at -878,291.00.

RevenueN/A
Gross ProfitN/A
Operating Income-878,291.00
Pretax Income6.21M
Net Income6.21M
EBITDA-878,291.00
EBIT-878,291.00
Earnings Per Share (EPS)N/A

Balance Sheet

Translational Development Acquisition Corp. holds 24,630.00 in cash and equivalents against 500,000.00 in total debt, resulting in a net debt position of 475,370.00. Total book value stands at 176.45M, with working capital of -785,769.00 providing operational flexibility.

Cash & Cash Equivalents24,630.00
Total Debt500,000.00
Net Debt475,370.00
Equity (Book Value)176.45M
Book Value Per ShareN/A
Working Capital-785,769.00

Cash Flow

Translational Development Acquisition Corp. produced -681,970.00 in operating cash flow over the past twelve months.

Operating Cash Flow-681,970.00
Capital ExpendituresN/A
Free Cash Flow-681,970.00
FCF Per ShareN/A

Scores

Translational Development Acquisition Corp. posts an Altman Z-Score of -0.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.07